https://scholars.lib.ntu.edu.tw/handle/123456789/627088
標題: | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | 作者: | WEI-WU CHEN CHIA-LANG HSU RUEY-LONG HONG JEN-CHIEH LEE Chang, Koping CHIH-WEI YU Chen, San-Chi JHE-CYUAN GUO Chen, Mei-Lu Hsu, Meng-Chi Kung, Ting-Fang ANN-LII CHENG Yen, Chueh-Chuan |
關鍵字: | B-CELLS; BEVACIZUMAB; CHEMOTHERAPY; COMPLEMENT; PAZOPANIB; SURVIVAL; TRIALS | 公開日期: | 1-十二月-2022 | 出版社: | AMER ASSOC CANCER RESEARCH | 卷: | 28 | 期: | 23 | 起(迄)頁: | 5058 | 來源出版物: | Clinical cancer research : an official journal of the American Association for Cancer Research | 摘要: | Satisfactory treatment options for advanced leiomyosarcoma and liposarcoma are limited. The LEADER study (NCT03526679) investigated the safety and efficacy of lenvatinib plus eribulin. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627088 | ISSN: | 1078-0432 | DOI: | 10.1158/1078-0432.CCR-22-2092 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。